Ipragliflozin add-on therapy to a GLP-1 receptor agonist in Japanese patients with type 2 diabetes (AGATE): a 52-week open-label study
Youll receive simple post-treatment guidelines
Raw peak data were processed using TraceFinder 5.0 and Xcalibur 4.0 software (Thermo Fisher Scientific), with peak alignment and detection performed according to the manufacturers protocol
Clinicians provide real-time supervision
Some of the notable trends are as follows: Substantial Investments in GLP-1 Peptide Manufacturing In March 2025, CordenPharma, a contract development and manufacturing organization (CDMO), announced its initiative to invest over Euro 500 million to build a new peptide development and manufacturing site in Muttenz, Basel region
This is especially important for individuals using medications like semaglutide, as they may need to be extra cautious about potential skin reactions